Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Trial Profile

Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 01 Apr 2021 Results (N=118) assessment of influence of genetic polymorphisms (pharmacogenetic assessment) published in the Clinical Therapeutics
  • 23 May 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
  • 10 Feb 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top